Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Cost of Revenue (2021 - 2025)

Pulse Biosciences (PLSE) has 3 years of Cost of Revenue data on record, last reported at $260000.0 in Q4 2025.

  • For Q4 2025, Cost of Revenue changed N/A year-over-year to $260000.0; the TTM value through Dec 2025 reached $260000.0, changed N/A, while the annual FY2025 figure was $539000.0, N/A changed from the prior year.
  • Cost of Revenue reached $260000.0 in Q4 2025 per PLSE's latest filing, down from $1.3 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $8.4 million in Q3 2022 and bottomed at $260000.0 in Q4 2025.
  • Average Cost of Revenue over 3 years is $2.2 million, with a median of $1.1 million recorded in 2022.
  • The widest YoY moves for Cost of Revenue: up 1055.43% in 2022, down 1055.43% in 2022.
  • A 3-year view of Cost of Revenue shows it stood at $727000.0 in 2021, then skyrocketed by 77.58% to $1.3 million in 2022, then tumbled by 79.86% to $260000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $260000.0 in Q4 2025, $1.3 million in Q4 2022, and $8.4 million in Q3 2022.